[The expression of lymphocytic function-associated antigen determined by IKO-11 monoclonal antibodies in patients with nephroblastoma and neuroblastoma].
The importance of NK-cells was shown in 12 patients with nephroblastoma and 10 patients with neuroblastoma using ICO-11 monoclonal antibodies. The numbers of circulating LFA-1+ cells were shown to be different in the untreated and treated patients. A certain regular influence of antitumour therapy on the amount of circulating LFA-1+ cells was established.
Torubarova
N A
NA
Baryshnikov
A Iu
AIu
Zikiriakhodzhaev
D Z
DZ
Sukhanova
E L
EL
Kadagidze
Z G
ZG
D000293:Adolescent; D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm / Q000032:analysis*; D000954:Antigens, Surface / Q000032:analysis*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007223:Infant; D007680:Kidney Neoplasms / Q000276:immunology* / Q000628:therapy; D007694:Killer Cells, Natural / Q000276:immunology; D016169:Lymphocyte Function-Associated Antigen-1; D008297:Male; D009447:Neuroblastoma / Q000276:immunology* / Q000628:therapy; D009396:Wilms Tumor / Q000276:immunology* / Q000628:therapy
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D016169:Lymphocyte Function-Associated Antigen-1
Ekspressiia limfotsitarnogo funktsiia-assotsiirovannogo antigena, opredeliaemogo monoklonal'nymi antitelami IKO-11, u bol'nykh nefroblastomoĭ i neĭroblastomoĭ.